| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702852 | American Journal of Ophthalmology | 2017 | 26 Pages |
Abstract
Repeated IV administrations of TCZ are well tolerated. TCZ (both 4 and 8Â mg/kg) is effective in improving VA and reducing VH and CMT in eyes with noninfectious intermediate uveitis, posterior uveitis, and panuveitis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Yasir Jamal Sepah, Mohammad Ali Sadiq, David S. Chu, Mark Dacey, Ron Gallemore, Pouya Dayani, Mostafa Hanout, Muhammad Hassan, Rubbia Afridi, Aniruddha Agarwal, Muhammad Sohail Halim, Diana V. Do, Quan Dong Nguyen,